Literature DB >> 6786493

Seatone is ineffective in rheumatoid arthritis.

E C Huskisson, J Scott, R Bryans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6786493      PMCID： PMC1505018          DOI： 10.1136/bmj.282.6273.1358

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Perna canaliculus in the treatment of arthritis.

Authors:  R G Gibson; S L Gibson; V Conway; D Chappell
Journal:  Practitioner       Date:  1980-09

2.  The anti-inflammatory activity of Perna canaliculus (NZ green lipped mussel).

Authors:  T E Miller; D Ormrod
Journal:  N Z Med J       Date:  1980-09-10
  2 in total
  8 in total

1.  Treating inflammation: some (needless) difficulties for gaining acceptance of effective natural products and traditional medicines.

Authors:  D E Butters; M W Whitehouse
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

2.  The use of 'alternative treatments' by patients with rheumatoid arthritis.

Authors:  G R Struthers; D L Scott; D G Scott
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

3.  Acute confusion secondary to steroid eye drops.

Authors:  Umar Farooq; Bander Dallol
Journal:  BMJ Case Rep       Date:  2014-12-24

Review 4.  Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus.

Authors:  Christopher S Cobb; Edzard Ernst
Journal:  Clin Rheumatol       Date:  2005-10-12       Impact factor: 2.980

5.  Seatone in rheumatoid arthritis: a six-month placebo-controlled study.

Authors:  J G Larkin; H A Capell; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

6.  In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus.

Authors:  Sachin Mani; John W Lawson
Journal:  BMC Complement Altern Med       Date:  2006-01-13       Impact factor: 3.659

7.  Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus).

Authors:  Anna Hielm-Björkman; Riitta-Mari Tulamo; Hanna Salonen; Marja Raekallio
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

8.  Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel.

Authors:  M W Whitehouse; T A Macrides; N Kalafatis; W H Betts; D R Haynes; J Broadbent
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.